Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities

Renal cell carcinoma (RCC) is among the top 10 most common cancers in both men and women with an estimated 75 000 cases each year in the US. Over the last decade, the therapeutic landscape for patients with metastatic RCC has significantly evolved, with immunotherapy emerging as the new front-line t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud, Ahmed M, Nabavizadeh, Reza, Rodrigues Pessoa, Rodrigo, Garg, Ishita, Orme, Jacob, Costello, Brian A, Cheville, John, Lucien, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078913/
https://www.ncbi.nlm.nih.gov/pubmed/36745503
http://dx.doi.org/10.1093/oncolo/oyac263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078913/
https://www.ncbi.nlm.nih.gov/pubmed/36745503
http://dx.doi.org/10.1093/oncolo/oyac263

Ejemplares similares